These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 1365682)

  • 41. Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast.
    Desai AA; Jimenez RE; Hoskin TL; Day CN; Boughey JC; Hieken TJ
    Ann Surg Oncol; 2018 Oct; 25(10):3064-3068. PubMed ID: 29947004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synchronous presentation of breast cancer and pheochromocytoma in a 57-year-old woman.
    Joseph KA; El-Tamer M; Ditkoff BA; Chabot J; Komenaka I; Horowitz L; Schnabel F; Shutter J
    Breast J; 2004; 10(1):63-4. PubMed ID: 14717766
    [No Abstract]   [Full Text] [Related]  

  • 44. Mammographic features of local recurrence in women who have undergone breast-conserving therapy for ductal carcinoma in situ.
    Liberman L; Van Zee KJ; Dershaw DD; Morris EA; Abramson AF; Samli B
    AJR Am J Roentgenol; 1997 Feb; 168(2):489-93. PubMed ID: 9016233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast-conserving surgery.
    Ohuchi N; Furuta A; Mori S
    Cancer; 1994 Aug; 74(4):1294-302. PubMed ID: 8055451
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ductal carcinoma in situ of the breast: progress and controversy.
    Swallow CJ; Van Zee KJ; Sacchini V; Borgen PI
    Curr Probl Surg; 1996 Jul; 33(7):553-600. PubMed ID: 8765465
    [No Abstract]   [Full Text] [Related]  

  • 47. Synchronous primary malignant tumors of the breast, caecum and sigma. Case report.
    Anania G; Santini M; Marzetti A; Scagliarini L; Vedana L; Resta G; Cavallesco G
    G Chir; 2012; 33(11-12):409-10. PubMed ID: 23140927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
    Claus EB; Stowe M; Carter D; Holford T
    Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.
    Rawal R; Lorenzo Bermejo J; Hemminki K
    Br J Cancer; 2005 Jan; 92(1):162-6. PubMed ID: 15570309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of ductal carcinoma in situ.
    Hetelekidis S; Schnitt SJ; Morrow M; Harris JR
    CA Cancer J Clin; 1995; 45(4):244-53. PubMed ID: 7600280
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
    Valdes EK; Boolbol SK; Cohen JM; Feldman SM
    Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [In situ carcinomas of the breast: clinical features and therapeutic strategies].
    Attene F; Scognamillo F; Trignano E; Meloni GB; Rubino C; Trignano M
    Ann Ital Chir; 2006; 77(1):3-10; discussion 10-2. PubMed ID: 16910353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variations in treatment of ductal carcinoma in situ of the breast: a population-based study in the East Netherlands.
    Schouten van der Velden AP; Van Dijck JA; Wobbes T
    Eur J Surg Oncol; 2007 May; 33(4):424-9. PubMed ID: 17084060
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
    Roder D; Webster F; Zorbas H; Sinclair S
    Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Second cancers following in situ carcinoma of the breast.
    Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
    Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer.
    Andersen J; Nielsen M; Christensen L; Ottesen GL; Blichert-Toft M
    Acta Chir Belg; 1987; 87(2):103-7. PubMed ID: 3591177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Radiotherapy in ductal in-situ breast carcinoma effective].
    Sauer R
    Strahlenther Onkol; 1993 Oct; 169(10):624-5. PubMed ID: 8235989
    [No Abstract]   [Full Text] [Related]  

  • 58. [Surgical treatment of carcinoma in situ of the breast].
    Gangi S; Costanzo MP; Furci M; Khansa K; Basile F
    Ann Ital Chir; 1995; 66(1):47-50; discussion 50-1. PubMed ID: 7668482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invasive lobular carcinoma in a patient with synchronous ductal carcinoma in situ: detection with MR imaging.
    Cooney BS; Orel SG; Schnall MD; Troupin RH
    AJR Am J Roentgenol; 1994 Jun; 162(6):1318-20. PubMed ID: 8191990
    [No Abstract]   [Full Text] [Related]  

  • 60. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast.
    Solin LJ; Fourquet A; Vicini FA; Taylor M; Olivotto IA; Haffty B; Strom EA; Pierce LJ; Marks LB; Bartelink H; McNeese MD; Jhingran A; Wai E; Bijker N; Campana F; Hwang WT
    Cancer; 2005 Mar; 103(6):1137-46. PubMed ID: 15674853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.